Biosignaling II Flashcards
Receptor tyrosine kinase structure
dimer structure (2 of each subunit)
alpha subunit ligand binding site
beta subunit integral protein (transmembrane)
enzyme active site on intracellular side with 3 Tyr residues
intrinsic protein kinase activity (to phosphorylate Tyr residues)
insulin RTK pathways intrinsic effects and cascade pathway mechanisms
targeted intrinsic effects: peripheral insulin sensitivity (glucose uptake), Beta cell development, and central leptin sensitivity
affects a lot of growth factors
secondary messengers: MAPK and PIP3 signaling cascades
activation of RTK
ligand binding causes phosphorylation of Tyrosines on activation loop on intracellular side, which is blocking the binding site
Conformational change of the activation loop leads to opening the binding site, to phosphorylate target proteins
function of insulin
regulates metabolic enzymes and gene expression
does not enter cell
MAPK pathway for insulin part 1 (up til start of MAPK)
- Insulin binds RTK and dimers autophosphorylate
- Insulin RTK phosphorylates IRS-1
- Grb2 (SH2) binds IRS-1 Tyr
- Sos binds Grb2
- Sos binds Ras, ousting GDP for GTP
- Active Ras binds Raf-1 (MAPKKK)
MAPK pathway for insulin part 2 (MAPK pathway)
- Raf-1 (MAPKKK) phosphorylates 2 Serine residues on MEK
- Mek (MAPKK) phosphorylates Thr and Tyr residues on ERK (MAPK)
- ERK (MAPK) moves into nucleus and phosphorylates TF to activate, like Elk1
- Elk1 and SRF transcription factors stimulate transcription of cell division genes
IRS-1
insulin receptor substrate 1
target protein that goes from RTK to MAPK pathway and to PI3K in GLUT transporter pathway/GS (glycogen synthase inactivation)
protein phosphorylation mechanism
ATP donates P and transferred to an acceptor protein
catalyzed by protein kinase enzymes
can activate or inactivate the target
PIP3 pathway for glucose
- IRS-1 (from RTK MAPK pathway) binds/activates PI3K enzyme
- PI3K enzyme converts PIP2 –> PIP3 via phosphorylation (membrane bound)
- PKB (protein kinase B) binds to PIP3, and is phosphorylated
- PKB phosphorylates GSK3 to be INACTIVE (so GS stays active, when GSK3 is active, it inactivates glycogen synthesis)
- PKB stimulates movement of GLUT4 receptors from vesicles to plasma membrane for increased glucose uptake into cell (muscle, fat and heart tissue)
PI3K
PIP3
phosphoinositide 3-kinase enzyme
phosphatidylinositol 3,4,5 triphosphate
GSK3
Glycogen synthase kinase 3
regulates glycogen synthesis
when inactive (phosphorylated) GS (glycogen synthase) remains active and synthesizes glycogen via phosphorylation by PKB in PIP3 pathway
when active, it phosphorylates GS (inactivating it), prevent glycogen synthesis
very active in muscle and liver tissue
where is PIP3 pathway for glucose very common
fat and muscle tissue
Structure and function of variations in RTK and growth factors
all have interior tyrosine kinase domains
extracellular receptors differ for each growth factor to bind different ligands
INSR kinase
insulin receptor kinase
phosphorylates tyrosine residues on beta-adrenergic receptor amplification of insulin signaling)
also phosphorylates IRS-1 in normal insulin pathways (PI3K and MAPK)
internalization of beta-adrenergic receptors due to insulin signaling
insulin receptor kinase (INSR) phosphorylates 2 Tyr on b-adrenergic receptor
Insulin-activated PKB phosphorylates 2 Ser residues on b-adrenergic receptor
result is internalization of beta-adrenergic receptors into vesicles